Itaconix PLC (AIM:ITX, OTCQB:ITXXF) said it was entering 2026 from a position of strength after delivering record revenues for the third year running, as demand for its plant-based polymers gathered pace across consumer goods markets.
The AIM-listed specialty chemicals group said the board remained optimistic about the year ahead, supported by a growing customer pipeline, wider adoption of its products and what it described as a scalable, capital-efficient operating model.
More detail on trading and outlook will be provided with full-year results, due in late March.
That confidence follows a milestone year in 2025. Unaudited revenues rose 59% to $10.3 million, up from $6.5 million in 2024, taking annual sales beyond $10 million for the first time.
Growth was driven by a third consecutive record half-year, with revenues of $5.5 million in the second half, compared with $4.8 million a year earlier.
The company said momentum came from both existing and new customers, across multiple geographies and applications.
Demand for its patented plant-based polymers has increased as large consumer product groups look to replace traditional ingredients with more sustainable alternatives that still deliver performance. Itaconix’s materials are used in products such as detergents, hygiene items and beauty formulations.
Management said the step-change in commercial traction had allowed the business to increase investment in demand generation and customer support ahead of 2026, without undermining financial discipline.
John Shaw, chief executive of Itaconix plc, said 2025 marked a turning point for the group.
“Delivering record revenues of over $10 million for the first time, alongside our third consecutive record half year, demonstrates the accelerating commercial momentum behind our technology and customer proposition,” he said.
“We are seeing growing validation from both new and existing customers as our plant-based specialty polymers become embedded in next-generation consumer products where performance, sustainability and value are all critical.”
Looking ahead, Shaw said the company was “well funded” and “capital efficient”, with a deepening pipeline of opportunities.
“With increasing scale, disciplined execution and strong customer engagement, we believe the company is firmly on track towards building a large, profitable and enduring specialty ingredients business,” he added.